HT
HZNP

HAP Trading’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

HAP Trading’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,506,400
Closed -$229K – 1262
2023
Q3 		$229K Sell
1,506,400
-97,200
-6% -$10.4M 0.04% 291
2023
Q2 		$1.4M Buy
1,603,600
+1,518,600
+1,787% +$160M 0.24% 89
2023
Q1 		$79K Sell
85,000
-882,000
-91% -$97.5M 0.01% 439
2022
Q4 		$9K Buy
+967,000
New +$80.3M ﹤0.01% 1139
2022
Q3 		– Sell
-17,700
Closed -$280K – 2235
2022
Q2 		$280K Sell
17,700
-3,300
-16% -$313K 0.01% 596
2022
Q1 		$210K Buy
21,000
+1,500
+8% +$146K 0.01% 834
2021
Q4 		$236K Buy
19,500
+6,700
+52% +$731K 0.01% 956
2021
Q3 		$119K Buy
+12,800
New +$1.33M ﹤0.01% 1209
2021
Q2 		– Sell
-207,400
Closed -$417K – 2787
2021
Q1 		$417K Sell
207,400
-3,400
-2% -$287K 0.02% 550
2020
Q4 		$887K Buy
+210,800
New +$15.7M 0.03% 451
2018
Q1 		– Sell
-190,000
Closed -$29K – 1282
2017
Q4 		$29K Buy
+190,000
New +$2.67M ﹤0.01% 747
2017
Q1 		– Sell
-960,300
Closed -$241K – 1361
2016
Q4 		$241K Buy
960,300
+731,500
+320% +$13.3M 0.01% 440
2016
Q3 		$242K Buy
228,800
+214,300
+1,478% +$4.19M 0.01% 468
2016
Q2 		$64K Sell
14,500
-2,400
-14% -$38.8K ﹤0.01% 568
2016
Q1 		$14K Sell
16,900
-56,600
-77% -$990K ﹤0.01% 664
2015
Q4 		$63K Buy
+73,500
New +$1.43M ﹤0.01% 611

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

HAP Trading's HZNP Position: Q3 2022 in Review

HAP Trading sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 10,475 shares — an estimated $835K sold.

HAP Trading first reported a position in HZNP in Q1 2014 and held it in 13 quarters. The position peaked at $8.68M in Q4 2020. 529 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

  • HAP Trading reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
  • HAP Trading sold 10,475 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $835K.
  • HAP Trading first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2014 and held it in 13 quarters.
  • HAP Trading's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $8.68M in Q4 2020.
  • 529 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on HAP Trading's 13F filing for Q3 2022, filed 14 Nov 2022.